Media coverage about Cooper Companies (NYSE:COO) has trended somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cooper Companies earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 47.5266925533849 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s scoring:
- Hydroponics companies expecting a flood of customers after marijuana is legalized (theglobeandmail.com)
- FY2018 EPS Estimates for Cooper Companies Inc Increased by William Blair (COO) (americanbankingnews.com)
- Domino® Sugar, C&H® Sugar Partner with DreamUp, NanoRacks, and Xtronaut to Launch Sugar into Space, Grow Crystals Aboard International Space Station (prweb.com)
- Northcoast Research Research Analysts Increase Earnings Estimates for Cooper Companies Inc (COO) (americanbankingnews.com)
- Q1 2018 EPS Estimates for Cooper Companies Inc Decreased by KeyCorp (COO) (americanbankingnews.com)
A number of brokerages have recently issued reports on COO. Jefferies Group reiterated a “buy” rating and set a $250.00 target price on shares of Cooper Companies in a report on Tuesday, September 12th. Stephens reissued an “equal weight” rating and set a $250.00 price target (up from $235.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a research report on Tuesday, October 10th. KeyCorp reissued a “hold” rating on shares of Cooper Companies in a research report on Monday, August 28th. Finally, Piper Jaffray Companies boosted their price target on Cooper Companies from $265.00 to $280.00 and gave the stock an “overweight” rating in a research report on Friday, September 1st. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Cooper Companies has an average rating of “Buy” and an average target price of $259.70.
Cooper Companies (NYSE:COO) traded up $1.89 during trading on Monday, reaching $228.45. The company had a trading volume of 774,286 shares, compared to its average volume of 427,958. The firm has a market cap of $11,110.00, a price-to-earnings ratio of 23.31, a PEG ratio of 1.83 and a beta of 0.54. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies has a 12-month low of $169.39 and a 12-month high of $256.39.
Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. Cooper Companies’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the previous year, the company posted $2.28 EPS. sell-side analysts anticipate that Cooper Companies will post 11.54 earnings per share for the current year.
In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.